INS and diabetes mellitus: In the 2017–2023 period, we generated a multivariable logistic regression where glycemic control (HBA1C < 7%) was the outcome, including all predictors associated with glycemic control as p < 0.1, adjusted for diabetes treatment status (insulin, oral medication, both, or neither).